Tulane University Health Sciences Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Tulane University Health Sciences Center designates this educational activity for a maximum of 45 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Administrators of the Tulane Educational Fund, dba Tulane University Health Sciences Center, and the New Orleans Internal Medicine Board Review and Recertification Group (Tulane, Ochsner, and LSU) present this activity for educational purposes only and does not endorse any product, content of presentation or exhibit. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected because of their recognized expertise.

It is the policy of the Center for Continuing Education at Tulane University Health Sciences Center to plan and implement all of its educational activities in accordance with the ACCME's Essential Areas and Policies to ensure balance, independence, objectivity and scientific rigor. In accordance with the ACCME’s 2004 Standards for Commercial Support, everyone who is in a position to control the content of an educational activity certified for AMA PRA Category 1 CreditTM is required to disclose all relevant financial relationships with any commercial interests within the past 12 months that creates a real or apparent conflict of interest. Individuals who do not disclose are disqualified from participating in a CME activity. Individuals with potential for influence or control of CME content include planners and planning committee members, authors, teachers, educational activity directors, educational partners, and others who participate, e.g. facilitators and moderators. This disclosure pertains to relationships with pharmaceutical companies, biomedical device manufacturers or other corporations whose products or services are related to the subject matter of the presentation topic. Any real or apparent conflicts of interest related to the content of the presentations must be resolved prior to the educational activity. Disclosure of off-label, experimental or investigational use of drugs or devices must also be made known to the audience.

The ABIM has requested that all involved in administering or teaching a Board review course print the following disclaimer: “The American Board of Internal Medicine is not affiliated with, nor does it endorse, any preparatory examination review program or other continuing medical education. The content of the New Orleans Internal Medicine Board Review and Recertification Course (course, syllabus, brochure, etc.) is developed independently by the New Orleans Internal Medicine Board Review and Recertification Group (LSU, Tulane and Ochsner) which has no knowledge of, or access to ABIM examination material.”